Literature DB >> 2716797

Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

D T Imagawa1, M H Lee, S M Wolinsky, K Sano, F Morales, S Kwok, J J Sninsky, P G Nishanian, J Giorgi, J L Fahey.   

Abstract

Infection with the human immunodeficiency virus type 1 (HIV-1), as demonstrated by viral cultures, has been described in some patients before antibodies to HIV-1 can be detected, but the duration and frequency of such latent infections are uncertain. We selected prospectively a cohort of 133 seronegative homosexual men who continued to be involved in high-risk sexual activity, and we cultured 225 samples of their peripheral-blood lymphocytes, using mitogen stimulation to activate the integrated HIV-1 genome. HIV-1 was isolated in blood samples from 31 of the 133 men (23 percent), 27 of whom have remained seronegative for up to 36 months after the positive culture. The other four men seroconverted 11 to 17 months after the isolation of HIV-1. In three of them, we studied cryopreserved lymphocytes obtained earlier, using the polymerase chain reaction to amplify small amounts of viral DNA, and we demonstrated that HIV-1 provirus had been present 23, 35, and 35 months before seroconversion. We conclude that HIV-1 infection in homosexual men at high risk may occur at least 35 months before antibodies to HIV-1 can be detected. A prolonged period of latency in such infections may be more common than previously recognized; the degree of infectiousness during such periods is unknown.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2716797     DOI: 10.1056/NEJM198906013202205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  83 in total

1.  Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Authors:  P A Zimmerman; A Buckler-White; G Alkhatib; T Spalding; J Kubofcik; C Combadiere; D Weissman; O Cohen; A Rubbert; G Lam; M Vaccarezza; P E Kennedy; V Kumaraswami; J V Giorgi; R Detels; J Hunter; M Chopek; E A Berger; A S Fauci; T B Nutman; P M Murphy
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  An AIDS model with distributed incubation and variable infectiousness: applications to i.v. drug users in Latium, Italy.

Authors:  M Iannelli; R Loro; F Milner; A Pugliese; G Rabbiolo
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

3.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

Review 5.  Transmission of hepatitis and AIDS: risks for the anaesthetist and the patient.

Authors:  C A Trépanier
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

6.  Detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction amplification and capture hybridization in microtiter wells.

Authors:  G H Keller; D P Huang; M M Manak
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

7.  Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.

Authors:  Janet M Young; Jim A Turpin; Runa Musib; Opendra K Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-15       Impact factor: 2.205

Review 8.  Infection and infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

Review 9.  The ethics of screening for early intervention in HIV disease.

Authors:  C Levine; R Bayer
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

10.  Direct detection of proviral gag segment of human immunodeficiency virus in peripheral blood lymphocytes by colorimetric PCR assay as a clinical laboratory tool applied to different at-risk populations.

Authors:  F Pane; S Buttò; M L Gobbo; M Franco; C Butteroni; L Pastore; G Maiorano; M Foggia; P T Cataldo; A Guarino
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.